Rosaria Casciaro
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Real-life effectiveness and safety of lumacaftor/ivacaftor in preschool children with cystic fibrosis: data from an italian multicentre study.
Journal: Pediatric research
Published: December 03, 2025
Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.
Journal: International journal of biological macromolecules
Published: October 16, 2025
Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.
Journal: International journal of biological macromolecules
Published: October 16, 2025
COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 31, 2025
A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices.
Journal: Pharmaceutics
Published: December 23, 2024
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study.
Journal: Life (Basel, Switzerland)
Published: August 30, 2024
Corrigendum to "Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor". J Pediatr. 2024 Jun 28; 274:114176.
Journal: The Journal of pediatrics
Published: August 28, 2024
Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor.
Journal: The Journal of pediatrics
Published: January 29, 2024
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study.
Journal: Frontiers in endocrinology
Published: November 30, 2023
Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.
Journal: Stem cell research
Published: September 01, 2023
The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus.
Journal: Respiratory medicine
Published: May 17, 2023
The Expression of Affective Temperaments in Cystic Fibrosis Patients: Psychopathological Associations and Possible Neurobiological Mechanisms.
Journal: Brain sciences
Published: March 17, 2023
Last Updated: 09/26/2026